跳至主要内容
临床试验/NCT01725035
NCT01725035已完成不适用

The Role of Hepatic De Novo Lipogenesis (DNL) in the Pathogenesis of Hepatic Steatosis in Obese Children and Adolescents

Yale University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2010年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
de novo lipogenesis response to high carbohydrate meal in obese kids with fatty liver

研究概览

简要总结

Nonalcoholic Fatty Liver Disease (NAFLD) is becoming the most common cause of liver disease in pediatrics, but little is known about its pathophysiology in children. While studies in obese adults with hepatic steatosis have described an increased hepatic de novo lipogenesis (DNL) depending on the diet, there are no studies exploring the mechanisms by which excess hepatic triglycerides increases in obese youths, thus explaining the accompanying dyslipidemia and the metabolic syndrome. The central hypothesis of this study is that hepatic conversion of carbohydrates to lipid (DNL) is enhanced and associated with accumulation of excess liver fat, dyslipidemia and hepatic insulin resistance in obese youths with hepatic steatosis. The overall goal is to examine whether hepatic DNL is increased in obese youths with steatosis compared to matched controls without steatosis.

Hypotheses: Hepatic conversion of carbohydrates to lipid (DNL) is enhanced and is associated with accumulation of excess liver fat, dyslipidemia and hepatic insulin resistance in obese youths with hepatic steatosis.

详细描述

In this study obese youths, adolescents and young adults (12-30 years) will undergo MRI (magnetic resonance imaging) measurement of liver lipid content to determine hepatic fat content. They will undergo a sugary drink (75 grams of glucose and 25 grams of fructose) challenge and Hepatic de novo lipogenesis will be determined as the incorporation of deuterium, from deuterium labeled water (D2O), into plasma triglycerides. Subjects will undergo a 6 hours study assessing de novo lipogenesis, an oral glucose tolerance test, dual energy x-ray absorptiometry, magnetic resonance imaging, and Euglycemic-Hyperinsulinemic Clamp.

This study record has been re-opened in 2019 and updated to reflect any changes having remained open since its inception with the Yale University IRB and also having obtained additional funding though NIDDK.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
12 Years 至 30 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Cases will meet the following criteria:
  • BMI higher than 75th percentile
  • Hepatic fat fraction (the amount of fat into the liver) greater or equal than 5.5%
  • Absence of any endocrinopathy
  • Absence of any therapy with medication known to alter glucose metabolism
  • Controls will meet the following criteria:
  • BMI higher than 75th percentile
  • Hepatic fat fraction (the amount of fat into the liver) lower than 5.5%
  • Absence of any endocrinopathy
  • Absence of any therapy with medication known to alter glucose metabolism
  • Absence of any therapy with medication known to alter glucose metabolism

排除标准

  • BMI under the 75th percentile
  • Hepatic fat fraction (the amount of fat into the liver) less than 5.5%
  • Absence of any endocrinopathy
  • Any therapy with medication known to alter glucose metabolism
  • Controls will meet the following criteria:
  • BMI under the 75th percentile
  • Hepatic fat fraction (the amount of fat into the liver) greater than or equal to 5.5%
  • Any endocrinopathy
  • Any therapy with medication known to alter glucose metabolism

结局指标

主要结局

de novo lipogenesis response to high carbohydrate meal in obese kids with fatty liver

时间窗: Study visit 3

次要结局

  • de novo lipogenesis response to high carbohydrate meal in obese kids without fatty liver(Study visit 3)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis... | 临床试验